CHECKPOINT INHIBITOR
Clinical trials for CHECKPOINT INHIBITOR explained in plain language.
Never miss a new study
Get alerted when new CHECKPOINT INHIBITOR trials appear
Sign up with your email to follow new studies for CHECKPOINT INHIBITOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a single drug free patients from insulin after immunotherapy?
Disease control Not yet recruitingThis pilot study tests whether the drug infliximab can safely reverse insulin dependence in people who developed diabetes after receiving checkpoint inhibitor cancer therapy. About 14 participants will be enrolled to check for side effects and see if insulin needs decrease. The g…
Matched conditions: CHECKPOINT INHIBITOR
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
Could a COVID shot boost liver cancer treatment?
Knowledge-focused Not yet recruitingThis study looks back at medical records of 200 liver cancer patients in Austria to see if getting an mRNA COVID-19 vaccine within three months before starting immunotherapy improves their response to cancer treatment. Researchers will also check if vaccination affects survival o…
Matched conditions: CHECKPOINT INHIBITOR
Sponsor: Medical University of Graz • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC